Diabetes mellitus, insulin treatment, diabetes duration, and risk of biliary tract cancer and hepatocellular carcinoma in a European cohort

MLA

Schlesinger, S., et al. Diabetes Mellitus, Insulin Treatment, Diabetes Duration, and Risk of Biliary Tract Cancer and Hepatocellular Carcinoma in a European Cohort. 2013. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1233961989&authtype=sso&custid=ns315887.

APA

Schlesinger, S., Aleksandrova, K., Pischon, T., Jenab, M., Fedirko, V., Trepo, E., Overvad, K., Roswall, N., Tjønneland, A., Boutron-Ruault, M. C., Fagherazzi, G., Racine, A., Kaaks, R., Grote, V. A., Boeing, H., Trichopoulou, A., Pantzalis, M., Kritikou, M., Mattiello, A., … Nöthlings, U. (2013). Diabetes mellitus, insulin treatment, diabetes duration, and risk of biliary tract cancer and hepatocellular carcinoma in a European cohort.

Chicago

Schlesinger, S, K Aleksandrova, T Pischon, M Jenab, V Fedirko, E Trepo, K Overvad, et al. 2013. “Diabetes Mellitus, Insulin Treatment, Diabetes Duration, and Risk of Biliary Tract Cancer and Hepatocellular Carcinoma in a European Cohort.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1233961989&authtype=sso&custid=ns315887.